Heyilimu Palashati

  • PhD student
 

Publications 2020

Zhang C, Palashati H, Rong Z, Lin N, Shen L, Liu Y, Li S, Yu B, Yang W, Lu Z (2020)
Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies
Mol Cancer, 19 (1), 162
DOI 10.1186/s12943-020-01282-7, PubMed 33218364

Publications 2019

Tan Q, Zhang C, Yang W, Liu Y, Heyilimu P, Feng D, Xing L, Ke Y, Lu Z (2019)
Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma
J Immunother Cancer, 7 (1), 232
DOI 10.1186/s40425-019-0709-7, PubMed 31462302

Publications 2018

Zhang C, Ding H, Huang H, Palashati H, Miao Y, Xiong H, Lu Z (2018)
TCR repertoire intratumor heterogeneity of CD4+ and CD8+ T cells in centers and margins of localized lung adenocarcinomas
Int J Cancer, 144 (4), 818-827
DOI 10.1002/ijc.31760, PubMed 30151844

Zhang C, Palashati H, Tan Q, Ku W, Miao Y, Xiong H, Lu Z (2018)
Immediate and substantial evolution of T-cell repertoire in peripheral blood and tumor microenvironment of patients with esophageal squamous cell carcinoma treated with preoperative chemotherapy
Carcinogenesis, 39 (11), 1389-1398
DOI 10.1093/carcin/bgy116, PubMed 30202955

Publications 2017

Tan Q, Ku W, Zhang C, Heyilimu P, Tian Y, Ke Y, Lu Z (2017)
Mutation analysis of the EBV-lymphoblastoid cell line cautions their use as antigen-presenting cells
Immunol Cell Biol, 96 (2), 204-211
DOI 10.1111/imcb.1030, PubMed 29363169

Page visits: 716